[1] World Health Organization. Suicide prevention(SUPRE) [Z]. [2012-08-06]. http://www.who.int/mental_health/prevention/suicide/suicideprevent/en/. [2] 李春秀,刘涛,徐晶,等. 自杀的病因学研究进展[J]. 中国健康心理学杂志, 2012, 20(9): 1439-1441. [3] 赵卫东,李力,黄坤. 自杀的研究现状与干预[J]. 现代预防医学, 2006, 33(11): 2065-2067. [4] 卢钟娇,贾志云,黄晓琦,等. 抑郁症自杀行为的神经生物学研究进展[J]. 生物医学工程学杂志, 2011, 28(4): 834-838. [5] 吴才智,陈真珍,于丽霞,等. 抑郁、绝望对自杀意念的影响:心理痛苦的中介作用[J]. 中国临床心理学杂志, 2015, 23(6): 1040-1043. [6] 童慧琦,徐俊冕,周云. 抑郁障碍中抑郁、绝望与自杀行为研究[J]. 中国心理卫生杂志, 1996, 10(2): 84-86. [7] 童慧琦,徐俊冕. 危机干预与自杀预防(二)抑郁、绝望及自杀行为(综述)[J]. 临床精神医学杂志, 1997, 7(4): 28-30. [8] 高宏生,曲成毅,苗茂华. 大学生自杀意念的社会心理影响因素研究[J]. 中华流行病学杂志, 2003, 24(9): 16-19. [9] C部分:自杀风险患者的治疗[J]. 中国心理卫生杂志, 2015, 29(S1): 62-88. [10] 王春江,刘献标,黄洁. 无抽搐电休克联合药物治疗抑郁症伴有自杀未遂患者效果分析[J]. 中外医学研究, 2014, 12(25): 42-43. [11] 施忠英,曹新妹,诸海英,等. 认知行为干预对抑郁症患者抑郁情绪和自杀态度影响的研究[J]. 上海护理, 2007, 7(6): 25-27. [12] 彭江发,刘奋,梁杰,等. 氯丙咪嗪静滴、无抽搐电休克及米氮平口服对抑郁症自杀观念急性干预的对照分析[J]. 精神医学杂志, 2012, 25(6): 424-426. [13] 陈黎明,况利,李大齐,等. 帕罗西汀联合无抽搐电休克治疗伴自杀倾向抑郁症的临床疗效及安全性[J]. 中国临床药理学杂志, 2016, 32(2): 153-155. [14] Bandelow B, Zohar J, Hollander E,等. 世界生物精神病学会联合会(WFSBP)关于焦虑障碍、强迫症和创伤后应激障碍的药物治疗指南[J]. 中国心理卫生杂志, 2003, 17(7): 485-507. [15] 王宇,苑成梅. 团体心理治疗在抑郁症中的新进展[J]. 上海交通大学学报(医学版), 2015, 35(8): 1217-1220. [16] 戴立磊,邹韶红,刘若楠,等. 重复经颅磁刺激对抑郁症患者自杀的影响[J]. 中国健康心理学杂志, 2015, 23(6): 801-805. [17] 潘能荣,杨小男,张承安,等. 电休克治疗对抑郁症的疗效研究[J]. 临床精神医学杂志, 2005, 15(2): 75-77. [18] 戴立磊,邹韶红,胡曼娜,等. 重复经颅磁刺激治疗抑郁症及对自杀风险影响的研究进展[J]. 国际精神病学杂志, 2015, 42(1): 132-135. [19] 胡希文,谭忠林,李达,等. 高频重复经颅磁刺激治疗抑郁症的研究进展[J]. 国际精神病学杂志, 2016, 43(1): 40-44. [20] Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression [J]. Neuron, 2005, 45(5): 651-660. [21] Hamani C, Machado DC, Hipolide DC, et al. Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor [J]. Biol Psychiatry, 2012, 71(1): 30-35. [22] Sousa SC, Almeida J, Cavaleiro MP, et al. Optimization of multiple coils immersed in a conducting liquid for half-hemisphere or whole-brain deep transcranial magnetic stimulation: a simulation study [J]. Conf Proc IEEE Eng Med Biol Soc, 2014, 2014: 538-541. [23] Zhang Y, Mao RR, Chen ZF, et al. Deep-brain magnetic stimulation promotes adult hippocampal neurogenesis and alleviates stress-related behaviors in mouse models for neuropsychiatric disorders [J]. Mol Brain, 2014, 7: 11. [24] Chiba S, Numakawa T, Ninomiya M, et al. Chronic restraint stress causes anxiety- and depression-like behaviors, downregulates glucocorticoid receptor expression, and attenuates glutamate release induced by brain-derived neurotrophic factor in the prefrontal cortex [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2012, 39(1): 112-119. [25] Naert G, Ixart G, Maurice T, et al. Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress [J]. Mol Cell Neurosci, 2011, 46(1): 55-66. [26] Porsolt RD, Anton G, Blavet N, et al. Behavioural despair in rats: a new model sensitive to antidepressant treatments [J]. Eur J Pharmacol, 1978, 47(4): 379-391. [27] Burghardt NS, Sigurdsson T, Gorman JM, et al. Chronic antidepressant treatment impairs the acquisition of fear extinction [J]. Biol Psychiatry, 2013, 73(11): 1078-1086. [28] Liu R, Dang W, Jianting M, et al. Citalopram alleviates chronic stress induced depression-like behaviors in rats by activating GSK3β signaling in dorsal hippocampus [J]. Brain Res, 2012, 1467: 10-17. [29] 张亚林. 精神病学[M]. 北京:人民教育出版社, 2005. [30] 杨福中,施慎逊. 强迫游泳实验研究应用及进展[J]. 上海精神医学, 2009, 21(3): 188-190. [31] Shanahan L, Copeland WE, Costello EJ, et al. Child-, adolescent- and young adult-onset depressions: differential risk factors in development? [J]. Psychol Med, 2011, 41(11): 2265-2274. [32] Schroeder M, Krebs MO, Bleich S, et al. Epigenetics and depression: current challenges and new therapeutic options [J]. Curr Opin Psychiatry, 2010, 23(6): 588-592. [33] Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation [J]. Psychopharmacology (Berl), 1997, 134(4): 319-329. |